Questioning Conclusions and Statements on the German HTA System: A Critical Perspective.
Saved in:
| Title: | Questioning Conclusions and Statements on the German HTA System: A Critical Perspective. |
|---|---|
| Authors: | Tomeczkowski J; Institute for Evidence-Based Positioning in the Health Care Sector at the University of Bonn, Bonn, Germany., Heidbrede T; UCB BioSciences, Monheim, Germany., Leverkus F; Pfizer Pharma, Berlin, Germany., Schmitter S; Pfizer Pharma, Berlin, Germany., Dintsios CM; Institute for Health Services Research and Health Economics, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Osowski U; Merck Healthcare Germany, Darmstadt, Germany., Herrmann KH; Pharming, Ottobrunn, Germany., Bluhmki T; Bristol-Myers Squibb, Munich, Germany., Marx A; Novartis AG, Nuremberg, Germany., Eichinger B; Novartis AG, Nuremberg, Germany., Basic E; Berlin School of Economics and Law, Berlin, Germany., Bussilliat P; vfa Berlin, Berlin, Germany., Dietrich ES; Institute for Evidence-Based Positioning in the Health Care Sector at the University of Bonn, Bonn, Germany. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Jan; Vol. 117 (1), pp. 22-23. Date of Electronic Publication: 2024 May 09. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1532-6535 |
|---|---|
| DOI: | 10.1002/cpt.3296 |
